Published in Arch Gynakol on January 01, 1976
Partial purification and properties of urokinase inhibitor from human placenta. J Biochem (1970) 1.14
Comparative studies of fibrinolytic inhibitors in vitro. Thromb Diath Haemorrh (1966) 1.04
Separation and characterization of two fibrinolytic inhibitors from human placenta. Thromb Diath Haemorrh (1971) 0.88
Inhibition of tissue activator by urokinase inhibitor. Thromb Diath Haemorrh (1971) 0.84
Plasminogen activator and urokinase inhibitor in myometrium, placenta, and amniotic fluid. Am J Obstet Gynecol (1969) 0.84
Failure to substantiate a low molecular weight inhibitor of fibrinolysis in blood. Nat New Biol (1973) 0.84
Natural proteinase inhibitors distribution, specificity, mode of action, and physiological significance. Z Klin Chem Klin Biochem (1972) 0.82
Abortion: is there a rational precept? Obstet Gynecol (1991) 1.38
The effect of saline loading on endotoxin-induced disseminated intravascular coagulation. J Lab Clin Med (1973) 1.28
The role of endotoxin in disseminated intravascular coagulation. Thromb Diath Haemorrh Suppl (1969) 1.18
Disseminated intravascular coagulation during the continuous infusion of endotoxin in rabbits. Morphologic and physiologic studies. Am J Obstet Gynecol (1969) 1.09
Fibrin derivatives, plasma hemoglobin and glomerular fibrin deposition in experimental intravascular coagulation. Thromb Diath Haemorrh (1973) 1.07
Effects of a variety of endotoxins on human and rabbit platelet function. Thromb Diath Haemorrh (1971) 1.05
Endotoxin-induced disseminated intravascular coagulation in nonpregnant rats. A new experimental model. Am J Pathol (1971) 1.04
Comparative studies of fibrinolytic inhibitors in vitro. Thromb Diath Haemorrh (1966) 1.04
Deposition of glomerular fibrin in the rabbit after infusion with endotoxin. Nature (1967) 1.01
Consumptive coagulopathy associated with intra-amniotic infusion of hypertonic salt. Am J Obstet Gynecol (1972) 1.00
Observations on the clotting of menstrual blood and clot formation. Am J Obstet Gynecol (1971) 0.98
Kidney tissue activator of fibrinolysis in relation to pregnancy. Obstet Gynecol (1968) 0.97
Properties of fibrinogenolysis and fibrinolysis products in immune assays. Thromb Diath Haemorrh (1967) 0.96
Disseminated intravascular coagulation in pregnancy. Clin Obstet Gynecol (1974) 0.93
Hematological studies during endotoxin infusion in rabbits. Thromb Diath Haemorrh (1968) 0.92
Effects of oral contraceptives on blood coagulation. A review. Obstet Gynecol Surv (1985) 0.90
Biochemical identification of the mucus of pseudomyxoma peritonei as the basis for mucolytic treatment. Am J Obstet Gynecol (1986) 0.90
Thromboembolic disease in pregnancy. Clin Obstet Gynecol (1968) 0.88
Ultrastructural comparison of endometriotic implants and eutopic endometrium. Am J Obstet Gynecol (1984) 0.87
Exchange transfusion experiments in rats inducing intravascular coagulation. Surg Gynecol Obstet (1972) 0.87
Prenatal diagnosis and perinatal management of a fetal ovarian cyst. Prenat Diagn (1985) 0.86
[Prenatal diagnosis from chorionic villi: results in Münster]. Geburtshilfe Frauenheilkd (1986) 0.86
Plasminogen activator and urokinase inhibitor in myometrium, placenta, and amniotic fluid. Am J Obstet Gynecol (1969) 0.84
Safety of placental biopsy in the second and third trimesters. N Engl J Med (1987) 0.84
Surgical complications and follow-up evaluation of 163 patients with subcutaneous mastectomy. Aesthetic Plast Surg (1987) 0.83
The identification of IUDs by ultrasound in the uterine cavity. Eur J Obstet Gynecol Reprod Biol (1975) 0.83
Clinical data of granulosa cell tumors. J Cancer Res Clin Oncol (1982) 0.82
Blood coagulation and fibrinolytic enzyme studies during cyclic and continuous application of progestational agents. Am J Obstet Gynecol (1967) 0.82
High molecular fibrin derivatives in pre-eclamptic and eclamptic patients. Eur J Obstet Gynecol Reprod Biol (1979) 0.81
[Report of a case of aplasia of the cervix and discussion of the embryology and clinical significance of the condition (author's transl)]. Geburtshilfe Frauenheilkd (1976) 0.81
Localization of fibrinolytic activity in uterine cancer. Am J Obstet Gynecol (1969) 0.81
[Contents of the fibrinolysis activator in the myometrium of the non-pregnant uterus and in labor]. Ginekol Pol (1965) 0.80
[Investigations on the contraceptive action of the Graefenberg ring. Historical review (author's transl)]. Geburtshilfe Frauenheilkd (1977) 0.80
Lack of coagulation defect after terminating second-trimester pregnancy by the catheter technique. Am J Obstet Gynecol (1973) 0.80
[Estimation of the plasminogen activation inhibitor in the euglobulin test]. Ginekol Pol (1966) 0.80
Coagulation studies of menopausal women taking estrogen replacement. Obstet Gynecol (1972) 0.79
[Treatment of obstetrical blood coagulation defects]. Zentralbl Gynakol (1973) 0.79
Thrombocytopenia indicating gram-negative infection and endotoxemia. Obstet Gynecol (1973) 0.79
Quantitation of the coagulation inhibition in vivo due to breakdown products of fibrin. Thromb Diath Haemorrh (1970) 0.79
Stilbestrol-augmented disseminated intravascular coagulation in rats after infusion of endotoxin. Am J Obstet Gynecol (1973) 0.79
The prevention of endotoxin-induced glomerular fibrin deposition by pyrimido-pyrimidine compounds. J Med (1972) 0.79
Fibrin deposition in the ribbit kidney produced by protease inhibitors. Thromb Diath Haemorrh (1967) 0.79
Septicemia during pregnancy: a study in different species of experimental animals. Am J Obstet Gynecol (1985) 0.78
The cerebral palsy story: a catastrophic misunderstanding in obstetrics. Obstet Gynecol Surv (1995) 0.78
The beginning of human life. J Assist Reprod Genet (1995) 0.78
[Early diagnosis of pre-eclampsia/eclampsia using disc electrophoresis]. Med Welt (1982) 0.78
Electron and light microscopy examination of capsules around breast implants. Plast Reconstr Surg (1977) 0.78
Augmentation of endotoxin-induced fibrin deposits by pregnancy and estrogen-progesterone treatment. Gynecol Invest (1972) 0.78
Tissue activator of the fibrinolytic enzyme in the female reproductive system. Obstet Gynecol (1969) 0.78
Comparative assays of tissue plasminogen activator in myometrium, cervix, and fibromyomas of the human uterus. Am J Obstet Gynecol (1971) 0.77
[Oxytocic action of thrombin on the rat uterus in vitro]. Ginekol Pol (1975) 0.77
Anticoagulant activity of peptides from the human placenta. Thromb Res (1979) 0.77
The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium. Eur J Obstet Gynecol Reprod Biol (1982) 0.77
Endodermal germ cell carcinoma (endodermal sinus tumor) of the vagina in infant girls. J Cancer Res Clin Oncol (1979) 0.77
Bilateral breast cancer: the frequency of undiagnosed cancers. Am J Obstet Gynecol (1986) 0.76
Evaluation of punch biopsy of the cervix under direct colposcopic observation (target punch biopsy). Obstet Gynecol (1966) 0.76
Low-dose endotoxin infusion: a new model? Am J Obstet Gynecol (1995) 0.76
[Central European study of the development of secondary sex characteristics in girls. I. Axillary hair as the 4th secondary sex characteristic]. Geburtshilfe Frauenheilkd (1988) 0.76
Coumarin necrosis of skin treated successfully with heparin. Obstet Gynecol (1971) 0.76
Primary carcinoma of the vagina. An analysis of 82 cases of squamous cell carcinoma. J Cancer Res Clin Oncol (1980) 0.75
Fetal lymphangiectasia--another cause for a positive amniotic fluid acetylcholinesterase test. Arch Gynecol (1986) 0.75
[Early and late complications following surgical abortion]. Arch Gynecol (1979) 0.75
[Investigation of the dalcon shield by scanning and transmission electronmicroscopy and bacteriologic studies (author's transl)]. Arch Gynakol (1976) 0.75
[Ultrasound localization of intrauterine contraceptive devices in the laboratory and in patients (author's transl)]. Arch Gynakol (1975) 0.75
Glomerular microcapillary thrombosis demonstrated by the new technique of immunocathodoluminescence. Am J Pathol (1975) 0.75
[Excessive uterine contractility as a risk factor of premature labor]. Ginekol Pol (1982) 0.75
[Plasma kinins in the course of labor]. Ginekol Pol (1971) 0.75
[On the content of plasminogen activator in human fetal tissues]. Ginekol Pol (1965) 0.75
[Incidence and causes of discoordination of uterine contractility--studies conducted by the method of external cardiotocography]. Ginekol Pol (1982) 0.75
[The formation of obstetric-neonatal-gynecological units. Their structure and function. A suggestion]. Ginekol Pol (1979) 0.75
[Diagnosis and treatment of constriction ring dystocia]. Ginekol Pol (1980) 0.75
[Blood coagulation disorders in the course of interrupted advanced pregnancy]. Ginekol Pol (1977) 0.75
[On the problem of shock classification in obstetrics]. Ginekol Pol (1968) 0.75
[Factors increasing susceptibility to neonatal hyaline membrane syndrome. III. Hypercoagulability and failure of the fibrinolytic system. Deficiency of alpha-1 antitrypsin and infection]. Pediatr Pol (1977) 0.75
[Twin pregnancy following pulmonary resection. Case report]. Wiad Lek (1968) 0.75
[Anti-urokinase activity of the blood serum in pregnant, delivering and postpartum wwomen]. Ginekol Pol (1974) 0.75
[Screening examination for detection of intrauterine fetal dystrophy]. Pol Tyg Lek (1982) 0.75
[Hemorrhage into the peritoneal cavity in cases of abruptio placentae]. Ginekol Pol (1979) 0.75
Urokinase inhibitor in human placenta. A thromboelastographic evaluation. Mater Med Pol (1973) 0.75
[Plasma kinins and uterine action during labor: facts and hypotheses]. Ginekol Pol (1971) 0.75
[Factors increasing susceptibility to neonatal hyaline membrane syndrome. II. Chronic intrauterine hypoxia, asphyxia and shock in newborn infants]. Pediatr Pol (1977) 0.75
Measurement of euglobulin fibrinolysis time in women with retarded fetal development. The effect of the clamping and step tests on plasminogen activator activity. Eur J Obstet Gynecol Reprod Biol (1980) 0.75
[Intrauterine fetal dystrophy in the Włocławek region. I. Diagnosis confirmed during the III trimester of pregnancy and after labor]. Ginekol Pol (1982) 0.75
[Incidence of obstetrical-risk pregnancies in the Włocławek region - prenatal and intrapartum risk and the state of the newborn infant]. Ginekol Pol (1982) 0.75
[Protamine and ethanol tests in pregnancy and puerperium]. Ginekol Pol (1973) 0.75
[Possibilities for continuing medical education in the United States]. Med Welt (1970) 0.75
[Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium]. Rocz Akad Med Im Juliana Marchlewskiego Bialymst (1971) 0.75
[Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment]. Pediatr Pol (1977) 0.75
[Apropos of diagnosis and therapy in the defibrination syndrome and in the increased fibrinolysis syndrome in obstetrics]. Ginekol Pol (1966) 0.75
[On the fibrinolytic activity of euglobulin in intact pregnancy and missed abortion]. Gynaecologia (1966) 0.75
[Usefulness of the Saling's list for the prediction of risk of premature labor]. Ginekol Pol (1982) 0.75
[Diagnosis of cervix dysplasia and electroconization]. Ginekol Pol (1983) 0.75
[Effect of the pregnant women serum on the contractility and electrobiological phenomena of the rat uterus in vitro]. Ginekol Pol (1968) 0.75
[Fibrinolysis activators and inhibitors present in the human myometrium during the menstrual cycle, in menopause, in pregnancy and labor]. Ginekol Pol (1974) 0.75
The effect of bradykinin upon human and rat myometrium contractility after blockade of adrenergic receptors in vitro. Pol Med J (1971) 0.75
Kininase activity in the human placenta. Biochem Pharmacol (1971) 0.75
[Hemorrhagic diathesis in cases of intrauterine fetal death]. Ginekol Pol (1968) 0.75
[Protein and peptide fribrinolysis inhibitor in human amniotic fluid]. Ginekol Pol (1980) 0.75
[Case of unidentified fever in the postoperative period - malignant hyperthermia syndrome?]. Ginekol Pol (1979) 0.75